(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PREDX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PREDX

ST13

US500000079382300

Class

5, 9, 10

Filing

79382300

Registration

7717724

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

04/03/2026

Trademark type

Word

Nice classes

5, 9, 10

Filing date

09/06/2023

Registration date

03/11/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/11/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

DE

Examiner

AMIN,NOOPUR H

Law office

O60

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Dermagnostix GmbH

Representatives

Nicholas Spencer Whitelaw Jordan IP Law, LLC

Technical classification

Nice Classes

Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medical diagnostic reagents and tests for testing of body fluids and tissue samples; chemical preparations for medical purposes and biochemical preparations for medical use and biotechnological preparations for medical usereagentsenzymes and buffer solutionsall for markingamplifyingquantification and/or for the analysis of biopolymersin particular nucleic acidsin particular reagentsenzymes and buffer solutions for nucleic acid amplification; kits containing diagnostic preparations for medical purposesin particular for markingamplifyingquantification and/or for the analysis of biopolymersin particular nucleic acidsin particular reagentsenzymes and buffer solutions for nucleic acid amplification

Class 9

Apparatus for scientific research and use in laboratoriesbiomarker test cartridges; diagnostic apparatus for measurement of biomarkers in the nature of genesgene expression levelsproteinsnot for medical purposes; biochips for research or scientific purposes; microfluid biochips for research or scientific purposes; lab-on-a-chip systems comprised of biochips for research or scientific purposes; laboratory devices and instruments in the nature of centrifuges for analysis and evaluation of lab-on-a-chip systems; laboratory test trays

Class 10

Medical instruments for measuring and testing biomarkers in tissuecellsliquids; tools for medical diagnosticsbiomarker test cartridges; apparatus for carrying-out diagnostic tests for medical purposesapparatus for measurement of biomarkers in the nature of genesgene expression levelsproteins

Publications

History of USPTO decisions and trademark events.

32 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/10/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/23/2025

FIMP

FINAL DISPOSITION PROCESSED

09/23/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/11/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/19/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/31/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

03/31/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

03/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/21/2025

PUBO

PUBLISHED FOR OPPOSITION

01/21/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/15/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/24/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

10/24/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/24/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

10/24/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/24/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/16/2024

GNFR

FINAL REFUSAL E-MAILED

10/16/2024

CNFR

FINAL REFUSAL WRITTEN

10/16/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/16/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/16/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/16/2024

RFNT

REFUSAL PROCESSED BY IB

06/03/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/13/2024

RFRR

REFUSAL PROCESSED BY MPU

05/13/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/04/2024

CNRT

NON-FINAL ACTION WRITTEN

05/03/2024

DOCK

ASSIGNED TO EXAMINER

05/02/2024

MAFR

APPLICATION FILING RECEIPT MAILED

11/07/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/03/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/02/2023

Continuous trademark protection

Get notified about every new filing that threatens PREDX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.